Hematology

The Pharmacy Times® Hematology Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of blood disorders, include blood and bone marrow cancers, anemia, hemophilia, blood-clotting disorders, and leukemia.

Latest News

Lymphoma Cancer Cell Hematology | Image Credit: catalin - stock.adobe.com
FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma

February 28th 2024

If approved, epcoritamab (DuoBody CD3xCD20; AbbVie, Genmab) would be the first and only subcutaneous bispecific antibody for treatment in this patient population.

FDA certified control department concept -- Image credit: wladimir1804 | stock.adobe.com
FDA Grants Orphan Drug Designation for Ocifisertib to Treat Patients With AML

February 21st 2024

3D image of white blood cells due to leukemia -- Image credit: SciePro | stock.adobe.com
Patients With CLL Present Heterogeneously

February 20th 2024

Health care worker holding wooden cubes with AML written -- Image credit: Dzmitry | stock.adobe.com
Clinical Overview of Quizartinib for Acute Myeloid Leukemia

February 15th 2024

Video Series
Video Interviews
Podcasts
Latest CME Events & Activities

Managed Care Insights on Optimizing the Use of BCMA-Targeted Treatments in Multiple Myeloma

1.5 Credits / Hematology, Oncology

View More

Understanding the Role of BCMA-Directed Therapy in the Management of Relapsed/Refractory Multiple Myeloma

1.25 Credits / Hematology, Oncology

View More

Clinical Conversations in Cancer Care: Preparing Pharmacists to Optimize Use of Bispecific Antibodies

1.5 Credits / Hematology, Oncology

View More

Innovations in Cancer Care: Examining the Emerging Role of Bispecific Antibodies in Relapsed/Refractory Lymphoma and Multiple Myeloma

1.5 Credits / Hematology, Oncology

View More

Preventing and Managing Controlled Substance Diversion Across Health Care Settings

2.0 Credits / Law

View More

Risks and Liabilities in Pharmacy Practice

1.0 Credit / Law

View More

CAR T-Cell Therapy Advances in Lymphoma: Implications for Managed Care

1.5 Credits / Hematology, Oncology

View More

Evidence-Based Oncology: Discerning Novel Approaches, Recent Advances, and the Managed Care Considerations for Targeted Treatments in CLL

2.0 Credits / Hematology, Oncology

View More

Leveraging Managed Care to Increase Access to BCMA-Directed Treatment and Equitable Care in Multiple Myeloma

1.5 Credits / Hematology, Oncology

View More

Leveraging Managed Care to Optimize Patient Outcomes in Acute Myeloid Leukemia

1.5 Credits / Hematology, Oncology

View More

New Pathways in Care for Myelofibrosis: Optimizing Treatment to Improve Outcomes

1.5 Credits / Hematology, Oncology

View More

Translating Progress in BCMA-Directed Therapy for Multiple Myeloma into Advances in Patient Care

1.0 Credit / Hematology, Oncology

View More

Ushering in a New Era of Targeted Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Focus on New and Emerging Antibody-Based Regimens

1.0 Credit / Hematology, Oncology

View More

Optimizing Outcomes for Older Patients With Acute Myeloid Leukemia: A Focus on Alternative Induction Regimens and Maintenance Therapy

1.0 Credit / Hematology, Oncology

View More

Treatment Strategies for Chronic Myeloid Leukemia and the Pharmacist’s Impactful Role

1.0 Credit / Hematology, Oncology

View More

Enhancing the Safety of Outpatient CAR T-Cell Administration in Relapsed/Refractory Lymphomas Through Pharmacist-Directed Initiatives

1.0 Credit / Hematology, Oncology

View More

Continuing the Conversation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Addressing Operational Challenges and Integrating New and Emerging Antibody-Based Regimens

1.0 Credit / Hematology, Oncology

View More

Navigating Current and Emerging Treatment Options for Myelofibrosis After Frontline Failure

1.0 Credit / Oncology

View More

Managed Care Considerations on the Evolving Role of Bispecific Antibodies in Hematologic Malignancies

1.5 Credits / Hematology, Oncology

View More

Continuing the Conversation in Myelofibrosis: The Role of Managed Care in Supporting Treatment Goals Through Appropriate Use of Emerging Therapies

1.0 Credits / Hematology, Oncology

View More

Caring for Patients With Chronic Graft-versus-Host Disease: The Important Role of Pharmacists on the Cancer Care Team

1.5 Credits / Hematology, Oncology

View More

Advancing Myelofibrosis Treatment and Management With JAK Inhibitors and Specialty Pharmacist-led Strategies

1.5 Credits / Hematology

View More

Clinical Updates in AML Induction and Maintenance Regimens and the Role of the Specialty Pharmacist

1.5 Credit(s) / Hematology, Oncology

View More

New Frontiers in the Treatment of Lower-Risk Myelodysplastic Syndromes and the Role of Oncology Pharmacists

1.5 Credit / Hematology, Oncology

View More

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Supporting Safe, Effective, and Equitable Access to B-Cell Maturation Antigen (BCMA)-Directed Treatments in Multiple Myeloma: Strategies for Specialty and Managed Care Pharmac...

1.5 Credit / Hematology, Oncology

View More

Exploring the Advancements in BTK Inhibitor Therapy for Mantle Cell Lymphoma and the Growing Impact of Oncology Pharmacists

1.0 Credit / Hematology, Oncology

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

Advances in the Treatment of Myelofibrosis: Updates and Considerations for Managed Care Professionals

1.0 Credit / Hematology, Oncology

View More

Assessing Emerging Therapies and Multidisciplinary Practices in Managing Myelofibrosis

1.5 Credits / Hematology, Oncology

View More

More News

© 2024 MJH Life Sciences

All rights reserved.